Author: svyrydov
Remoni Health and Topcon Healthcare Partner to Redefine Continuous Care in Chronic Eye Disease Advancing remote monitoring, care continuity, and proactive management beyond the clinic
Jan 13, 2026
Remoni Health is proud to announce a new commercial partnership with Topcon Healthcare, a global leader in digital health, ocular imaging, and AI-enabled diagnostics. As eye care expands beyond episodic visits, the ability to stay connected with patients throughout their journey enables better coordination, ongoing support, and improved long-term outcomes.
Read MoreRemoni Health Completes 80,000 Remote Monitoring Encounters for Chronic Retina Diseases
Dec 18, 2024
Achieves doubling in remote patient enrollment. Plans Expanded Launch of RH 2.0 Care Management Platform
Read MoreRemoni Health launches breakthrough specialty care management service for eye care
Oct 17, 2023
In the fast-evolving landscape of healthcare, Remoni Health (formerly KYS Vision, Inc.) is making a significant impact with its Vision-as-a-Service (VaaS) solutions. Remoni Health is taking eye care to the next level by expanding its vision monitoring platform to include comprehensive care management services. Eye doctors and clinics now have access to cutting-edge tools, including […]
Read MoreARVO Showcase: Unlocking New Horizons in Retinal Disease Management with Digital Remote Monitoring
Apr 28, 2023
We had the privilege of presenting our groundbreaking study on the Macustat test at ARVO, where we explored the patient’s perspective on the effectiveness of digital remote monitoring. As pioneers in this field, our focus was to assess patient satisfaction and outcomes using a digital platform for monitoring chronic disease progression in retina patients. Our […]
Read MoreThe retina practice enters the future of digital health: Dr. Gentile’s perspective on remote home monitoring for AMD patients
Jan 02, 2023
Dr. Gentile, professor of ophthalmology at NYEE and leading retina surgeon shares personal experience and practice innovation insights after incorporating digital health and remote patient monitoring for his cutting-edge Manhattan practice
Read MoreMacustat study highlights Digital Health advancements with evidence-based remote monitoring tools in Ophthalmic Press
Nov 01, 2022
The study is one of the first clinical trials to validate the clinical utility of real-world remote physiologic monitoring using an on-demand vision-as-a-service extension to the specialty retina clinic to enable remote monitoring of patients with chronic diseases such as AMD, diabetic retinopathy, and other retinal conditions
Read MoreRemoni Health Reports Clinical Trial Results of Its Remote Physiologic Monitoring System for Patients with Chronic Retinal Conditions
Oct 22, 2022
Remoni Health, an eye care digital health company, today announced the clinical trial results of its Macustat® macular function scan for the remote monitoring of central retinal function. The study was published in the peer-reviewed journal Digital Health in October 2022 (Digital Health. 2022;8)
Read MoreRemoni Health completes development of VaaS remote patient monitoring platform; adds industry veterans to Corporate Board
Sep 01, 2022
Remoni Health completes the development of the first Vision-as-a-Service (VaaS) remote patient monitoring platform. Adds industry veterans Jim Mazzo and Dr. Joe Gira to Corporate Board. Expands Advisory Board with Dr. Bob Avery, Dr. Sophie Bakri, Dr. Celso, Dr. Rishi Singh, and David Cox
Read MoreTelehealth revolutionizes patient eye health with Remote Diagnostic Testing and Machine Learning: Dr. Cal Roberts of Lighthouse Guild
Jun 15, 2022
Today’s big idea is: How will remote diagnostic tests change ophthalmology and vision care? It might be a foreign concept for some, but the specialists in today’s episode, Dr. Peter Pham and Dr. Sean Ianchulev, founders of (Remoni Health, a VaaS company focused on remote diagnostic vision tests) share how they can conduct more reliable perimetry tests that help detect macular degeneration, glaucoma, and other conditions that lead to vision loss and eventually blindness — remotely, while patients stay home.
Read More